Pfizer says Covid-19 pill near 90% effective in final analysis
December 21, 2021
Pfizer’s final analysis of its antiviral Covid-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients. Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.
Back »
